Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hyperscale Data (GPUS) Research & Development (2016 - 2025)

Hyperscale Data (GPUS) has disclosed Research & Development for 16 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • Quarterly Research & Development fell 65.09% to $1.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Sep 2025, up 35.8% year-over-year, with the annual reading at $11.0 million for FY2024, 149.23% up from the prior year.
  • Research & Development for Q3 2025 was $1.6 million at Hyperscale Data, up from $112000.0 in the prior quarter.
  • The five-year high for Research & Development was $6.2 million in Q4 2024, with the low at $102000.0 in Q2 2024.
  • Average Research & Development over 5 years is $1.2 million, with a median of $695000.0 recorded in 2022.
  • Peak annual rise in Research & Development hit 456.55% in 2024, while the deepest fall reached 94.35% in 2024.
  • Over 5 years, Research & Development stood at $384000.0 in 2021, then skyrocketed by 115.62% to $828000.0 in 2022, then skyrocketed by 34.54% to $1.1 million in 2023, then soared by 456.55% to $6.2 million in 2024, then plummeted by 74.11% to $1.6 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $1.6 million, $112000.0, and $129000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.